ViroMed Co. Ltd. | Income Statement

Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
Sales/Revenue
5,746
6,138
7,695
6,844
3,158
Cost of Goods Sold (COGS) incl. D&A
884
925
929
808
856
Gross Income
4,862
5,213
6,767
6,036
2,301
SG&A Expense
4,463
4,948
5,466
7,999
9,370
EBIT
378
246
1,106
-
7,116
Unusual Expense
768
578
1,038
539
153
Non Operating Income/Expense
416
262
111
446
1,233
Interest Expense
-
-
-
-
77
Pretax Income
266
159
317
714
6,496
Income Tax
1
-
60
-
-
Consolidated Net Income
266
159
257
714
6,496
Net Income
266
159
257
714
6,496
Net Income After Extraordinaries
266
159
257
714
6,496
Net Income Available to Common
266
159
257
714
6,496
EPS (Basic)
18.37
10.64
17.40
49.00
407.00
Basic Shares Outstanding
15
15
15
15
16
EPS (Diluted)
18.21
10.80
17.50
49.02
407.10
Diluted Shares Outstanding
15
15
15
15
16
EBITDA
1,125
806
1,645
1,582
6,654
Other Operating Expense
21
18
194
20
48
Non-Operating Interest Income
240
227
139
284
1,779

About ViroMed Co.

View Profile
Address
203 Bldg. Natural Science College
Seoul SL 08733
Korea, Republic Of
Employees -
Website http://www.viromed.co.kr
Updated 09/14/2018
ViroMed Co., Ltd. engages in the development and manufacture of biopharmaceuticals for human diseases. It operates through the Natural Materials and Biomedical Products Business Divisions. Its products include technologies for diseases.